SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063359
Filing Date
2023-11-14
Accepted
2023-11-14 07:50:34
Documents
50
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20230930.htm   iXBRL 10-Q 1555502
2 EX-31.1 hcwb-ex31_1.htm EX-31.1 15947
3 EX-31.2 hcwb-ex31_2.htm EX-31.2 16078
4 EX-32.1 hcwb-ex32_1.htm EX-32.1 10720
5 EX-32.2 hcwb-ex32_2.htm EX-32.2 10430
6 GRAPHIC img113183884_0.jpg GRAPHIC 63079
  Complete submission text file 0000950170-23-063359.txt   4838418

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hcwb-20230930_cal.xml EX-101.CAL 29722
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20230930.xsd EX-101.SCH 28562
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hcwb-20230930_def.xml EX-101.DEF 130621
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20230930_pre.xml EX-101.PRE 195237
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20230930_lab.xml EX-101.LAB 271093
44 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20230930_htm.xml XML 588131
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 231401621
SIC: 2834 Pharmaceutical Preparations